Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 228

Results For "LA"

8967 News Found

Singlera Genomics announces research collaboration with Astellas Pharma
Biotech | April 06, 2022

Singlera Genomics announces research collaboration with Astellas Pharma

The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals


Aster MIMS Hospital completes 50 kidney swap transplants
Hospitals | April 06, 2022

Aster MIMS Hospital completes 50 kidney swap transplants

The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


BioFluidica to introduce next-generation biomarker isolation platform
Biotech | April 06, 2022

BioFluidica to introduce next-generation biomarker isolation platform

BioFluidica LiquidScan harnesses the power of microfluidics


GE Healthcare and Elekta sign global collaboration agreement
News | April 06, 2022

GE Healthcare and Elekta sign global collaboration agreement

GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets


Dr Lal PathLabs to use drones for sample collection and diagnostic access
Clinical Trials | April 05, 2022

Dr Lal PathLabs to use drones for sample collection and diagnostic access

Pilots to be launched across multiple locations in India.


BSV strengthens women's health portfolio by acquiring Tidilan brand
News | April 05, 2022

BSV strengthens women's health portfolio by acquiring Tidilan brand

It is currently available in tablet and injectable dosage forms


Trescal launches its single source calibration solution across Australia and New Zealand
Biotech | April 05, 2022

Trescal launches its single source calibration solution across Australia and New Zealand

Trescal provides precision calibration expertise in every industry, geography and instrument across the world


Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US